GJB2 and hearing loss disorder: Since a large number of GJB2 mutation patients have late onset of hearing loss, pinpointing the molecular mechanism of the mutation could help formulate strategies to prevent or delay hearing loss in this specific patient population [22] and develop potential treatments.